Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,860,000 | 2,040,000 | 929,000 | 3,538,000 | 2,435,000 |
| Depreciation Amortization | 2,220,000 | 1,483,000 | 744,000 | 2,849,000 | 2,134,000 |
| Income taxes - deferred | -404,000 | -50,000 | 32,000 | -460,000 | -291,000 |
| Accounts receivable | 18,000 | -89,000 | 196,000 | -435,000 | 86,000 |
| Other Working Capital | 284,000 | -507,000 | -153,000 | -1,403,000 | -524,000 |
| Other Operating Activity | 129,000 | 145,000 | -198,000 | 1,129,000 | 52,000 |
| Operating Cash Flow | $5,107,000 | $3,022,000 | $1,550,000 | $5,218,000 | $3,892,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 932,000 | 1,515,000 | 60,000 | 4,518,000 | -492,000 |
| PPE Investments | -924,000 | -598,000 | -330,000 | -1,046,000 | -693,000 |
| Net Acquisitions | -1,328,000 | -1,306,000 | -12,000 | -1,213,000 | -1,132,000 |
| Other Investing Activity | 21,000 | 32,000 | -2,000 | -14,000 | -11,000 |
| Investing Cash Flow | $-1,299,000 | $-357,000 | $-284,000 | $2,245,000 | $-2,328,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,122,000 | 1,158,000 | 926,000 | 146,000 | 1,362,000 |
| Debt Issued | 131,000 | 131,000 | 33,000 | N/A | 0 |
| Debt Repayment | -361,000 | -252,000 | -17,000 | -5,132,000 | -1,612,000 |
| Common Stock Issued | 309,000 | 260,000 | 214,000 | 491,000 | 360,000 |
| Common Stock Repurchased | -3,409,000 | -2,794,000 | -1,763,000 | -2,830,000 | -2,170,000 |
| Dividend Paid | -1,782,000 | -1,192,000 | -599,000 | -2,139,000 | -1,608,000 |
| Other Financing Activity | 20,000 | 38,000 | 46,000 | -79,000 | -9,000 |
| Financing Cash Flow | $-3,970,000 | $-2,651,000 | $-1,160,000 | $-9,543,000 | $-3,677,000 |
| Exchange Rate Effect | 54,000 | 64,000 | 78,000 | 113,000 | -9,000 |
| Beginning Cash Position | 2,876,000 | 2,876,000 | 2,876,000 | 4,843,000 | 4,843,000 |
| End Cash Position | 2,768,000 | 2,954,000 | 3,060,000 | 2,876,000 | 2,721,000 |
| Net Cash Flow | $-108,000 | $78,000 | $184,000 | $-1,967,000 | $-2,122,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,107,000 | 3,022,000 | 1,550,000 | 5,218,000 | 3,892,000 |
| Capital Expenditure | -924,000 | -598,000 | -330,000 | -1,046,000 | -693,000 |
| Free Cash Flow | 4,183,000 | 2,424,000 | 1,220,000 | 4,172,000 | 3,199,000 |